[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334761-105":59,"doc-detail-334761-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","clinicopathological-features-and-molecular-signatures-of-lateral-neck-lymph-node-metastasis-in-papillary-thyroid-microcarcinoma","Clinicopathological Features and Molecular Signatures of Lateral Neck Lymph Node Metastasis in Papillary Thyroid Microcarcinoma","","Predictive factors for lateral neck lymph node metastasis (LLNM) in papillary thyroid microcarcinoma (PTMC) remain unclear. This retrospective, multi-institution study evaluated clinicopathological features, transcriptomic profiles, and tumor microenvironment characteristics in relation to LLNM status. Patients without nodal metastasis (N0) were compared with those with LLNM (N1b), including matched metastatic lymph node samples, with validation using external transcriptomic resources and immunohistochemistry. Male sex, multifocality, extrathyroidal extension, lymphatic invasion, and central node metastasis associated with higher LLNM risk, while increased tumor-associated macrophages, especially M2 macrophages, supported tumor progression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinicopathological-features-and-molecular-signatures-of-lateral-neck-lymph-node-metastasis-in-papillary-thyroid-microcarcinoma/334761/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinicopathological-features-and-molecular-signatures-of-lateral-neck-lymph-node-metastasis-in-papillary-thyroid-microcarcinoma/334761.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical factors were associated with LLNM in PTMC?","Question",{"text":112,"@type":113},"Male sex, multifocality, extrathyroidal extension, lymphatic invasion, and central node metastasis showed associations with LLNM in PTMC.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were transcriptomic differences between N0 and N1b PTMC evaluated?",{"text":117,"@type":113},"Laser capture microdissection and RNA sequencing were performed on primary tumors, with metastatic lymph nodes included for the N1b group; external RNA-seq data from BRAF-like PTMCs were used for corroboration.",{"name":119,"@type":110,"acceptedAnswer":120},"What did tumor microenvironment analyses reveal about LLNM?",{"text":121,"@type":113},"Deconvolution and immunohistochemistry indicated increased tumor-associated macrophages in the N1b group, particularly M2 macrophages, suggesting support for tumor progression and LLNM.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334761,1790120922,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":4},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Original Article  \nEndocrinol Metab 2024;39:324-333 [https://doi.org/10.3803/EnM.2023.1885](https://doi.org/10.3803/EnM.2023.1885)[ ](https://doi.org/10.3803/EnM.2023.1885)[pISSN 2093-596X](pISSN 2093-596X) · eISSN 2093-5978  \nClinicopathological Features and Molecular Signatures of Lateral Neck Lymph Node Metastasis in Papillary Thyroid Microcarcinoma  \nJinsun Lim1, *, Han Sai Lee2, *, Jin-Hyung Heo3, Young Shin Song2  \n1CHA University School of Medicine, Seongnam; 2Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul; 3Department of Pathology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea  \nBackground: The predictive factors for lateral neck lymph node metastasis (LLNM) in papillary thyroid microcarcinoma (PTMC) remain undetermined. This study investigated the clinicopathological characteristics, transcriptomes, and tumor microenvironment in PTMC according to the LLNM status. We aimed to identify the biomarkers associated with LLNM development.  \nMethods: We retrospectively reviewed the medical records of patients with PTMC from two independent institutions between 2018 and 2022 (n = 597 and n = 467). We compared clinicopathological features between patients without lymph node metastasis (N0) and those with LLNM (N1b). Additionally, laser capture microdissection and RNA sequencing were performed on primary tumors from both groups, including metastatic lymph nodes from the N1b group (n = 30; 20 primary tumors and 10 paired LLNMs) . We corroborated the findings using RNA sequencing data from 16 BRAF-like PTMCs from The Cancer Genome Atlas. Transcriptomic analyses were validated by immunohistochemical staining.  \nResults: Clinicopathological characteristics, such as male sex, multifocality, extrathyroidal extension, lymphatic invasion, and central node metastasis showed associations with LLNM in PTMCs. Transcriptomic profiles between the N0 and N1b PTMC groups were similar. However, tumor microenvironment deconvolution from RNA sequencing and immunohistochemistry revealed an increased abundance of tumor-associated macrophages, particularly M2 macrophages, in the N1b group.  \nConclusion: Patients with PTMC who have a male sex, multifocality, extrathyroidal extension, lymphatic invasion, and central node metastasis exhibited an elevated risk for LLNM. Furthermore, infiltration of M2 macrophages in the tumor microenvironment potentially supports tumor progression and LLNM in PTMCs.  \nKeywords: Thyroid cancer, papillary; Lymphatic metastasis; Biomarkers, tumor; Tumor microenvironment  \nReceived: 19 November 2023, Revised: 5 January 2024, Accepted: 25 January 2024  \nCorresponding author: Young Shin Song  \nDepartment of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 07061, Korea  \nTel: +82-2-870-2210, Fax: +82-2-831-2826, [E-mail:](E-mail: yssongmd@gmail.com)[ yssongmd@gmail.com](E-mail: yssongmd@gmail.com)[ ](E-mail: yssongmd@gmail.com)*These authors contributed equally to this work.  \nCopyright © 2024 Korean Endocrine Society  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by-nc/4.0/](licenses/by-nc/4.0/)) [which permits unrestricted non-commercial use](which permits unrestricted non-commercial use), distribution, and reproduction in any medium, provided the original work is properly cited.  \n324 [www.e-enm.org](www.e-enm.org)  \nBiomarker Predicting Lateral LN Metastasis in PTMC  \nINTRODUCTION  \nPapillary thyroid microcarcinoma (PTMC), defined as papillary thyroid carcinoma (PTC) with a maximal diameter of 10 mm or less, typically exhibits an indolent course and favorable prognosis. Recent thyroid cancer guidelines propose active surveillance as an alternative to immediate","cbCaiphjRsNep8sP","https://ap.wps.com/l/cbCaiphjRsNep8sP","pdf",3850303,12,"English","# Introduction\n# Methods\n# Results\n# Conclusion\n# Biomarker Predicting Lateral LN Metastasis in PTMC\n## Patients and tissue samples","[{\"question\":\"What clinical factors were associated with LLNM in PTMC?\",\"answer\":\"Male sex, multifocality, extrathyroidal extension, lymphatic invasion, and central node metastasis showed associations with LLNM in PTMC.\"},{\"question\":\"How were transcriptomic differences between N0 and N1b PTMC evaluated?\",\"answer\":\"Laser capture microdissection and RNA sequencing were performed on primary tumors, with metastatic lymph nodes included for the N1b group; external RNA-seq data from BRAF-like PTMCs were used for corroboration.\"},{\"question\":\"What did tumor microenvironment analyses reveal about LLNM?\",\"answer\":\"Deconvolution and immunohistochemistry indicated increased tumor-associated macrophages in the N1b group, particularly M2 macrophages, suggesting support for tumor progression and LLNM.\"}]","Clinicopathological Features and Molecular Signatures of Lateral Neck Lymph Node Metastasis in Papillary Thyroid Microcarcinoma | PDF",1790008255]